drugset / Trial / NCT00655681

Prevention of Post Operative Bone Loss in Children

NCT00655681

RandomizedParallel-groupQuadruple-blindPrevention

Summary

Hypothesis: one-dose pamidronate will prevent post-operative bone loss in children at risk for low bone density Plan: children with chronic disease such as CP, spina bifida, etc. will be recruited pre operatively and studied with DXA scan. After surgery, children will be randomized to receive either pamidronate or saline. Repeat DXA scan will determine bone lost after end of immobilization or nonweightbearing.

Timeline

Start
2007-09
Primary completion
2011-08
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Pamidronate Small molecule 1 mg/kg Intravenous